Ыcientists explore 1510 influenza pandemic and lessons learned

November 12, 2010

History's first recognized influenza pandemic originated in Asia and rapidly spread to other continents 500 years ago, in the summer of 1510. A new commentary by researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, explores the 1510 pandemic and what we have learned since then about preventing, controlling and treating influenza.

Prior to that time, regional and local epidemics of respiratory and pneumonia had occurred, but no outbreaks had yet been recorded on a worldwide scale. The 1510 pandemic first arose in Asia, but it spread quickly to and Europe via trade routes. Although the disease—which was then referred to by various descriptive terms such as "gasping oppression"—was highly infectious, the death rate was low, and the pandemic ended quickly.

The authors concede that the emergence of new pandemic influenza viruses remains as unpredictable as it was 500 years ago. But they outline a host of scientific and public health advances that have taken place since then—from the study of microbiology to the development of vaccines and treatment—that now allow us to better plan and prepare for both seasonal and influenza. For example, scientists at NIAID and elsewhere are currently researching the possibility of a universal vaccine, which would aim to protect individuals from all strains of flu.

More information: DM Morens et al. Pandemic influenza's 500th anniversary (http://dx.doi.org/10.1086/657429). Clinical Infectious Diseases. DOI:10.1086/657429 (2010).

Related Stories

Recommended for you

New trials offer hope for TB treatment

October 28, 2016

Researchers at the University of St Andrews are one step closer to finding a shorter, more effective treatment for TB, according to a new paper published by The Lancet Infectious Diseases.

Fatty liver: Turning off TAZ reverses disease

October 27, 2016

Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.